Results 171 to 180 of about 1,850,678 (233)

Efficacy and safety of 2% isosorbide cream in systemic sclerosis patients with digital ulcers and Raynaud's phenomenon. [PDF]

Rheumatol Immunol Res
Namvijit S, Foocharoen C, Suwannaroj S, Pongkulkait P, Onchan T, Mahakkanukrauh A.   +5 more
europepmc   +1 more source

Validity and psychometric characteristics of the Duruöz Hand Index (DHI) with systemic sclerosis. [PDF]

Rheumatol Int
Duruöz MT, Öz N, Karabulut Y, Erdem Gürsoy D, Gezer HH, Acer Kasman S.   +5 more
europepmc   +1 more source

Osteoclastogenesis in Patients With Systemic Sclerosis With and Without Calcinosis Cutis. [PDF]

ACR Open Rheumatol
Valenzuela A, Pérez G, Chung L, Sánchez F, Iturriaga C, Montalva R, Borzutzky A.   +6 more
europepmc   +1 more source

Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study. [PDF]

Rheumatology (Oxford)
De Luca G, De Lorenzis E, Campochiaro C, Cacciapaglia F, Del Papa N, Zanatta E, Airò P, Lazzaroni MG, Giuggioli D, De Santis M, Alonzi G, Stano S, Binda M, Moccaldi B, Tonutti A, Cavalli S, Batani V, Natalello G, Iannone F, D'Agostino MA, Dagna L, Matucci-Cerinic M, Bosello SL.   +22 more
europepmc   +1 more source

Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease. [PDF]

J Scleroderma Relat Disord
Khanna D, Evnin LB, Assassi S, Benton WW, Gordon G, Maslova K, Steffgen J, Maher TM.   +7 more
europepmc   +1 more source

Scleroderma (Systemic Sclerosis) [PDF]

, 2010
Scleroderma is a systemic disease characterized by progressive fibrosis of the skin and multiple organs. The term “scleroderma” means literally “hard skin”
J. A. Al-Tubaikh
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Scleroderma (Systemic Sclerosis)

100 Short Cases for the MRCP, 2020
K. Gupta, P. Carmichael, A. Zumla
openaire   +3 more sources

Scleroderma–Systemic Sclerosis

Clinical Immunology, 2019
John Varga, Fredrick M. Wigley
openaire   +2 more sources

Scleroderma: Systemic Sclerosis

2013
Liam Zakko, Marti J. Rothe, Jane M. Grant-Kels, Justin Finch   +3 more
openaire   +3 more sources